Login / Signup
Ustekinumab and Vedolizumab Exposure Is Unaffected by Pharmacogenetic Determinants of Anti-TNFs Pharmacokinetics.
Dahham Alsoud
Bram Verstockt
Severine Vermeire
Published in:
Inflammatory bowel diseases (2024)
Keyphrases
</>
ulcerative colitis
patients with inflammatory bowel disease